Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.
[esophageal adenocarcinoma]
In
the
current
study
we
present
a
validated
miRNA
signature
to
predict
pathologic
complete
response
(
pCR
)
to
neoadjuvant
chemoradiation
in
esophageal
adenocarcinoma
.
Three
patient
cohorts
(
discovery
,
n
 
=
 
10
;
model
,
n
 
=
 
43
;
and
validation
,
n
 
=
 
65
)
with
locally
advanced
esophageal
adenocarcinoma
were
analyzed
.
In
the
discovery
cohort
754
miRNAs
were
examined
in
pretreatment
tumor
biopsy
specimens
using
a
TaqMan
array
.
Of
these
,
the
44
most
significantly
altered
between
tumors
with
pCR
and
non-p
CR
were
examined
in
an
additional
43
tumors
using
a
Fluidigm
48
.
48
array
.
The
4
miRNAs
(
mir-
505
*
,
mir-
99
b
,
mir-
451
,
and
mir-
145
*
)
significantly
predicting
pCR
in
both
cohorts
were
examined
in
an
additional
validation
cohort
(
n
 
=
 
65
)
using
an
Illumina
array
.
These
4
miRNAs
were
used
to
generate
an
miRNA
expression
profile
(
MEP
)
score
.
The
4
miRNAs
profiled
are
highly
significantly
associated
with
pCR
in
the
model
cohort
(
Ptrend
 
=
 
.
008
)
,
the
validation
cohort
(
Ptrend
 
=
 
.
025
)
,
and
the
combined
cohort
(
Ptrend
 
=
 
4
.
6
×
10
(
-
4
)
)
.
The
receiver-operator
characteristic
areas
under
the
curves
(
AUCs
)
for
the
MEP
score
were
0
.
78
for
the
model
cohort
,
0
.
71
for
the
validation
cohort
,
and
0
.
72
for
the
combined
cohort
.
When
combined
with
clinical
variables
,
the
MEP
score
AUCs
increased
to
0
.
89
,
0
.
77
,
and
0
.
81
,
respectively
Estimates
from
logistic
regression
based
on
the
MEP
were
determined
and
used
to
generate
a
probability
of
pCR
plot
,
which
identifies
a
group
of
patients
with
very
high
(
≥
80
%
)
and
very
low
(
≤
10
%
)
probability
of
pCR
.
The
MEP
score
provides
a
validated
means
of
predicting
pCR
to
neoadjuvant
chemoradiotherapy
in
esophageal
adenocarcinoma
that
is
robust
across
several
analysis
platforms
.
Cancer
2014
;
120
:
3635
-
3641
.
©
2014
The
Authors
.
Cancer
published
by
Wiley
Periodicals
,
Inc
.
on
behalf
of
American
Cancer
Society
.
Diseases
Validation
Diseases presenting
"locally advanced esophageal adenocarcinoma"
symptom
esophageal adenocarcinoma
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom